Related Experiment Video

Updated: Jul 12, 2025

Quantification of Hypopigmentation Activity In Vitro
06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

11.4K

Vitiligo-like hypopigmentation induced by dabrafenib-trametinib: a potential marker for clinical response

Elena Carmona-Rocha1,2, Ivana Sullivan2,3, Oriol Yélamos1,2

  • 1Dermatology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona.

Melanoma Research
|October 27, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

913
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.4K

Related Experiment Videos

Last Updated: Jul 12, 2025

Quantification of Hypopigmentation Activity In Vitro
06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

11.4K
Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

913
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.4K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

2.0K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.0K

Articles linked to this work by shared authors, journal, and citation graph.

Reflectance Confocal Microscopy-Optical Coherence Tomography-Guided Laser Ablation of Low-Risk Basal Cell Carcinoma: A Long-Term Prospective Follow-Up Study.

Lasers in surgery and medicine·2026

Imaging-guided tape stripping reveals consistent stratum corneum profiling of disease severity and treatment-responsive molecular features in pediatric atopic dermatitis.

Journal of dermatological science·2026

Expression of LIFR in tumor and SHOC2, YAP1 in plasma mRNA as potential biomarkers in KRAS G12C NSCLC.

Scientific reports·2026

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial.

Nature communications·2025

CD274 (PD-L1) Polymorphisms as Predictors of Efficacy in First-Line Platinum-Based Chemotherapy for Extensive-Stage Small Cell Lung Cancer.

International journal of molecular sciences·2025

Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial.

Lung cancer (Amsterdam, Netherlands)·2025

DPM2 promotes melanoma progression and serves as a prognostic factor.

Melanoma research·2026

Targeted BRAF /MEK inhibition as a salvage therapy for patients with metastatic melanoma harboring a BRAF L597R mutation: two case reports and review of the literature.

Melanoma research·2026

Evidence of genetic susceptibility to immune-related dermatitis in patients with melanoma treated with immune checkpoint inhibitors.

Melanoma research·2026

Successful 15-step desensitization protocol for nivolumab and ipilimumab after a skin-test confirmed anaphylaxis to polysorbate 80: case report.

Melanoma research·2026

Treatment discontinuation after complete response to BRAF/MEK inhibition in metastatic melanoma: long-term clinical outcomes from a single institution.

Melanoma research·2026

Melanoma simulators: a retrospective study of nonmelanocytic mimickers.

Melanoma research·2026

Fibromyalgia and Central Sensitization in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: A Systematic Review.

Cureus·2026

Isolated Central Nervous System Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome-Case Report and Literature Review.

Respirology case reports·2026

When Pneumonia Is Not Pneumonia: T-cell Acute Lymphoblastic Leukemia Presenting With Mediastinal Mass, Airway Compression, and Pericardial Effusion in a 4-Year-Old.

Cureus·2026

Suspected Biphasic Anaphylaxis Following the First Known Dose of Tirzepatide: A Case Report and Brief Review of Reported Hypersensitivity Reactions.

Cureus·2026

Anti-PAR2 autoantibodies are associated with chronic histological injury in kidney transplant recipients.

Frontiers in immunology·2026

The Potential Allergic Role of Mast Cells to Orthodontic Appliance in Orthodontic-Induced Gingival Enlargement.

Oral health & preventive dentistry·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us